American Diversified Holdings Corporation
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- American Diversified Holdings Corporation American Diversified Holdings Corporation (ADHC) operates as a holding company focused on artificial intelligence-based technology development in the healthcare sector, providing executive management, corporate governance, administrative support, financial advisory services, and introductions to capital sources primarily to micro-cap public companies; it also develops medical AI applications and operates e-commerce platforms in the wellness industry, including sites such as universalwellnessshop. The company, founded in 2001 and headquartered at 122 15th Street, Del Mar, California, maintains a small team of approximately three employees and targets the health care technology segment with an emphasis on mobile healthcare platforms tailored for patient monitoring, ailment-specific protocols, bio device technologies, and innovative wellness solutions. In recent developments, American Diversified Holdings Corporation completed the acquisition of GlucoGuard, an AI-driven medical device technology from IMD Solutions in Phoenix, Arizona, enhancing its portfolio in non-invasive glucose monitoring and medical diagnostics as announced in October 2025; it continues to advance AI-focused medical technologies while shifting from traditional consulting services toward integrated healthcare innovation through strategic technology acquisitions.
Company News
GlucoGuard, a Division of American Diversified Holdings (ADHC), Has Completed an Investors Deck Focused on Funding Research Required for FDA Approval
American Diversified Holdings Corporation Announces Planned Spin-Off of GlucoGuard Into Separate Public Company and Special Share Dividend for ADHC Shareholders
American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA
American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division
GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program
American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund
Metavesco: ADHC Joins OTCfi Movement With Treasury Purchase
American Diversified Holdings Corporation (ADHC) Provides Udpate on Arete Bioscience GlucoGuard Design Project
GlucoGuard Receives $43 Million Enterprise Valuation Research Report
Harbinger Research Publishes Coverage Initiation Report, on American Diversified Holdings Corporation (ADHC) and Its Operating Division, GlucoGuard
GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program
American Diverisfied Holdings Corporation (ADHC) to Retain San Diego Based Bio Device Engineering Firm, Arete Bioscience, to Design GlucoGuard's Oral Diabetes Management Device
American Diversified Holdings Corporation (ADHC) Receives Favorable FDA Review
GlucoGuard Files Breakthrough Device Application with US Food and Drug Administration
American Diversified Holdings Corporation Forms Strategic Alliance with Tech Kahunas LLC a Leading Technology, Cyber-Security and Software Development Firm
American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program
American Diversified Holdings Corporation (ADHC) Retains Dr. Stephen C. Weber, MD, FACS As Head of Medical Advisory Board
Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration
American Diversified Holdings Corporation (ADHC) Completes Acquisition Of GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients
American Diversified Holdings Corporation (ADHC) to Acquire GlucoGuard, a AI-Based Medical Device for Managing Nocturnal Hypoglycemia in Diabetic Patients